Clinical Trials on Chronic Hepatitis C Virus Infection in Belgium

Total 738 results

Osivax
Center for vaccinology (CEVAC), University of Ghent, Belgium

Completed

A Prospective Epidemiological Cohort Study Evaluating Occurrences of Influenza-like Illness.

Influenza

Belgium
GlaxoSmithKline

Completed

Study to Evaluate the Immunogenicity & Safety of an Investigational Influenza Vaccine (H1N1) in Adults

Influenza

Belgium
GlaxoSmithKline

Completed

Safety Study of Four Candidate Influenza Vaccines to Prevent Influenza Disease in the Elderly Population

Influenza

Belgium
GlaxoSmithKline

Completed

Study to Evaluate the Immunogenicity and Safety of 2 Formulations of GlaxoSmithKline (GSK) Biologicals' GSK1247446A Low Dose Influenza Vaccine Candidate

Influenza

Belgium
GlaxoSmithKline

Completed

Safety Study of an Adjuvanted Candidate Influenza Vaccine to Prevent Influenza Disease in the Elderly Population

Influenza

Belgium
Seqirus
Novartis Vaccines

Completed

Safety, Tolerability, and Immunogenicity of Different Combinations of Trivalent Influenza Vaccine Varying Influenza Antigen Dose, Adjuvant Dose, and Route of Administration in Healthy Elderly Individuals Ages 65 Years and Older

Influenza

Belgium
Visterra, Inc.

Completed

Influenza Challenge Study of VIS410 in Healthy Volunteers

Influenza

Belgium
Crucell Holland BV

Completed

Clinical Study for Safety and Immunogenicity Study of Influenza Vaccine

Influenza

Belgium
Novartis
Novartis Vaccines

Completed

A Dose Ranging Study Comparing Different Combinations of Adjuvanted and Non-adjuvanted Influenza Vaccines in Healthy Children 6 to <36 Months of Age

Influenza

Belgium
Gilead Sciences

Completed

Efficacy, Pharmacokinetics, and Safety of Presatovir in Hospitalized Adults With Respiratory Syncytial Virus (RSV) Infection

Respiratory Syncytial Virus Infection

Korea, Republic of, Australia, Israel, New Zealand, Netherlands, United States, France, United Kingdom, Italy, Belgium, Poland
Ablynx

Withdrawn

Efficacy and Safety of ALX-0171 in Adult Hematopoietic Stem Cell Transplant (HSCT) Recipients Who Present With Respiratory Syncytial Virus (RSV) Infection

Respiratory Syncytial Virus Lower Respiratory Tract Infection

Belgium, Spain, Australia
Grand Medical Pty Ltd.
Trium Clinical Consulting

Completed

A Study to Evaluate the Safety and Effect of STC3141 Continuous Infusion in Subjects With Severe Corona Virus Disease 2019（COVID-19）Pneumonia

Severe COVID-19 Pneumonia

Belgium
Solvay Pharmaceuticals

Completed

Annual Study to Investigate Inactivated Subunit Influenza Vaccine for the 2006/2007 Influenza Season in Europe.

Healthy Volunteers

Belgium
LiteVax BV
University Hospital, Ghent; HarmonyCR, Melle, Belgium

Recruiting

Safety, Tolerability, Immunogenicity and Immunological Mechanisms of TETRALITE, a Novel Seasonal Influenza Vaccine (TETRALITE-Ib)

Vaccination Reaction

Belgium
Novartis Vaccines

Completed

Humoral and Cell Mediated Immunity and Safety of MF59C.1-adjuvanted Subunit Influenza Vaccine or a Conventional Subunit Influenza Vaccine in Previously Unvaccinated Healthy Subjects

Influenza | Seasonal Influenza | Human Influenza | Influenza Due to Unspecified Influenza Virus

Belgium
Algemeen Ziekenhuis Maria Middelares

Unknown

Propofol Versus Sevoflurane During FESS

Sinus Infection Chronic

Belgium
Novartis Vaccines

Completed

Safety and Immunogenicity of a Subunit Trivalent Nonadjuvated Influenza Study Vaccine in Adults Aged 18 Years and Above

Human Influenza

Belgium
Novartis Vaccines

Completed

Safety and Immunogenicity of a Subunit Trivalent Influenza Vaccine, Northern Hemisphere Formulation 2013/2014, in Healthy Adults Aged 18 Years and Above

Human Influenza

Belgium
Immune Targeting Systems Ltd

Completed

Safety and Reactogenicity of a H1N1 Influenza Challenge Virus in Healthy Volunteers

Influenza A

Belgium
Sciensano

Completed

COVID-19 Vaccination Uptake in Belgium : Sociodemographic and Socioeconomic Disparities

COVID-19

Belgium
Cliniques universitaires Saint-Luc- Université...
Society for Anesthesia and Resuscitation of Belgium

Completed

Survey: COVID-19 Patients Managed in the Operating Theatre of Belgian Hospitals (COVID)

COVID-19

Belgium
AstraZeneca
Iqvia Pty Ltd

Completed

Evaluate the Safety and Tolerability, for Nirsevimab in Immunocompromised Children (MUSIC)

RSV Infection

United States, Belgium, Spain, Japan, Poland, South Africa, United Kingdom, Ukraine
Jessa Hospital
Hasselt University; University Hospital, Antwerp

Active, not recruiting

Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients (MIA-COVID-19)

COVID-19

Belgium
University Hospital, Ghent

Terminated

Nasal Continuous Positive Airway Pressure (CPAP) in Chronic Fatigue and Sleep-disordered Breathing

Chronic Fatigue With OSA | Chronic Fatigue Syndrome With OSA

Belgium
University Hospital, Ghent

Recruiting

The Potential of Oral Camostat in Early COVID-19 Disease in an Ambulatory Setting to Reduce Viral Load and Disease Burden

Covid19

Belgium
Dr David DE BELS

Completed

Determination of the Hemoadsorption Impact as Adjunctive Treatment Upon the Support Therapy of COVID-19

Covid19

Belgium
Moens Maarten
STIMULUS research group, Vrije Universiteit Brussel

Completed

Profiling of Post Covid-19 Infection Patients: an Online Survey (PRESTO)

Covid19

Belgium
Sciensano
Jessa Hospital

Completed

Immune Response to Covid-19 in 300 Health Care Workers With Mild Symptoms

COVID-19 | Serology

Belgium
Universitaire Ziekenhuizen KU Leuven

Recruiting

Residual SARS-CoV-2 Presence in the Respiratory Tract and Lung Parenchyma (After SARS-CoV-2 Infection or COVID-19) (REASSURE)

Covid19

Belgium
Brugmann University Hospital

Completed

Are Surgeons Ready to Get the COVID-19 Vaccine?

Covid19

Belgium
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intradermal Route)

Influenza

Belgium
Jessa Hospital

Completed

Predictive Value of SOFA and APACHE Scores for In-hospital Mortality in COVID-19 ICU Patients

Covid19

Belgium
Regeneron Pharmaceuticals

Completed

A Trial to Learn if a COVID-19 Therapeutic is Safe and Well Tolerated, and How it Works in the Body of Healthy Adult Participants

Healthy

Belgium
Sciensano
Institute of Tropical Medicine, Belgium; Erasme University Hospital; Mensura...

Completed

COVID-19: Safety and Immunogenicity of a Reduced Dose of the BioNTech/Pfizer BNT162b2 Vaccine (REDU-VAC)

Covid19

Belgium
Universiteit Antwerpen
Vrije Universiteit Brussel; Université Libre de Bruxelles; Sciensano

Active, not recruiting

Vaccination Against COVID-19 in Pregnant and Lactating Women in Belgium (PREGCOVAC)

Covid19

Belgium
University of Liege
Laboratoires SMB S.A.

Completed

Effect of Vitamin D on Hospitalized Adults With COVID-19 Infection

Covid19

Belgium
Murielle Surquin

Completed

Elderly Patients and COVID-19 Infection: a Cohort of Fifty Patients Over Ninety Years of Age

Covid19

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Surgical Face Mask Effects in Patients With COVID-19

Covid19

Belgium
Jessa Hospital

Completed

Bacterial Surinfections in COVID-19 ICU Patients

Covid19

Belgium
GlaxoSmithKline

Completed

A Study to Evaluate the Safety and Ability of the Vaccine to Induce Antibodies Against the Respiratory Syncytial Virus in Healthy Adults

Respiratory Syncytial Virus (RSV)

Belgium
University Hospital, Angers

Completed

Point Of Care UltraSonography for Risk-stratification of COVID-19 Patients (POCUSCO)

Coronavirus Infection | COVID

France, Belgium
Hanane EL KENZ

Completed

Reduction of COVID 19 Transmission to Health Care Professionals

COVID 19

Belgium
Jessa Hospital

Completed

Descriptive Study Regarding Ambulant Screening During COVID-19 Pandemia

COVID 19

Belgium
Brugmann University Hospital

Recruiting

Long-term Effects of SARS-CoV-2 on the Central Nervous System and One-year Follow-up of "Long COVID-19" Patients

Long Covid19

Belgium
Hasselt University

Recruiting

Changes in Cardiac and Pulmonary Hemodynamics as Predictor of Outcome in Hospitalized COVID-19 Patients (COVID-HO)

Covid-19

Belgium
Aquilon Pharmaceuticals S.A.

Terminated

Clinical Trial to Assess the Efficacy and Safety of Inhaled AQ001S in the Management of Acute COVID-19 Symptoms (SIROCCO-1)

Covid19

Belgium
University Hospital, Ghent
University Ghent

Completed

SeroCovid<19: Covid-19 Seroconversion in Tertiary Pediatric Patients

Covid19 | Children, Only

Belgium
Vrije Universiteit Brussel
Universitair Ziekenhuis Brussel

Completed

COVID-19 and the Brain

Covid19 | Brain | fMRI | Neurocognition

Belgium
Universitair Ziekenhuis Brussel

Recruiting

SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the UZ Brussel Following COVID-19 Vaccination Using an Adenoviral Vector

Covid19 | SARS-CoV-2

Belgium
OSE Immunotherapeutics

Recruiting

To Evaluate the Safety, and Immunogenicity of Vaccine Candidate Against COVID-19, in Healthy Adults (COVEPIT 3)

Coronavirus Disease (COVID-19)

Belgium

3

Subscribe